The effect of high dose melatonin on cardiac ischemia-reperfusion injury

Yonsei Medical Journal

Volumn 49, Issue 5, 2008, Pages 735-741

  Ceyran, Hakan ^a   Narin, Figen ^a   Narin, Nazmi ^a   Akgün, Hülya ^a   Ceyran, A Bahar ^b   Öztürk, Figen ^a   Akçali, Yiǧit ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^b National Hospital   (Turkey)

Author keywords

Antioxidant; Fas and Bcl 2 expression; Melatonin; Myocardial ischemia reperfusion

Indexed keywords

ENZYME; FAS ANTIGEN; FREE RADICAL; MALONALDEHYDE; MELATONIN; MYELOPEROXIDASE; PROTEIN BCL 2; SUPEROXIDE DISMUTASE; TROPONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; ENZYME ACTIVITY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PATHOGENESIS; PROTEIN BLOOD LEVEL; RAT; REPERFUSION INJURY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; MALE; MALONDIALDEHYDE; MELATONIN; MYOCARDIAL REPERFUSION INJURY; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; TROPONIN;

EID: 58149468825     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2008.49.5.735     Document Type: Article

References (25)

1. Hearse DJ, Bolli R. Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc Res 1992;26:101-8.
2. Yue TL, Ma XL, Wang X, Romanic AM, Liu GL, Louden C, et al. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ Res 1998;82:166-74.
3. Kaneko S, Okumura K, Numaguchi Y, Matsui H, Murase K, Mokuno S, et al. Melatonin scavenges hydroxyl radical and protects isolated rat hearts from ischemic reperfusion injury. Life Sci 2000;67:101-12.
4. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993;1:57-60.
5. Reiter RJ, Poeggeler B, Tan DX, Chen LD, Manchester LC, Cuerrero JM. Antioxidant capacity of melatonin: a novel action not requiring receptor. Neuro Endocrinol Lett 1993;15:103-16.
6. Fjaerli O, Lund T, Osterud B. The effect of melatonin on cellular activation processes in human blood. J Pineal Res 1999;26:50-5.
7. Hearse DJ, Tosaki A. Reperfusion-induced arrhythmias and free radicals: studies in the rat heart with DMPO. J Cardiovasc Pharmacol 1987;9:641-50.
8. Jeremias I, Kupatt C, Martin-Villalba A, Habazettl H, Schenkel J, Boekstegers P, et al. Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia. Circulation 2000;102:915-20.
9. Salie R, Harper I, Cillie C, Genade S, Huisamen B, Moolman J, et al. Melatonin protects against ischaemic-reperfusion myocardial damage. J Mol Cell Cardiol 2001;33:343-57.
10. Basaga HS. Biochemical aspects of free radicals. Biochem Cell Biol 1990;68:989-98.
11. Rodríguez AB, Nogales G, Ortega E, Barriga C. Melatonin controls superoxide anion level: Modulation of superoxide dismutase activity in ring dove heterophils. J Pineal Res 1998;24:9-14.
12. Cuzzocrea S, Costantino G, Mazzon E, Micali A, De Sarro A, Caputi AP. Beneficial effects of melatonin in a rat model of splanchnic artery occlusion and reperfusion. J Pineal Res 2000;28:52-63.
13. Haider KH, Stimson WH. Cardiac myofibrillar proteins: biochemical markers to estimate myocardial injury. Mol Cell Biochem 1999;194:31-9.
14. Ohno M, Takemura G, Ohno A, Misao J, Hayakawa Y, Minatoguchi S, et al. "Apoptotic" myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: analysis by immunogold electron microscopy combined with in situ nick end-labeling. Circulation 1998;98:1422-30.
15. Reiter R, Tang L, Garcia JJ, Mu⊤noz-Hoyos A. Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci 1997;60:2255-71.
16. Ianǎs O, Olinescu R, Badescu I. Melatonin involvement in oxidative processes. Endocrinologie 1991;29:147-53.
17. Sainz RM, Mayo JC, Uría H, Kotler M, Antolín I, Rodriguez C, et al. The pineal neurohormone melatonin prevents in vivo and in vitro apoptosis in thymocytes. J Pineal Res 1995;19:178-88.
18. Bettahi I, Pozo D, Osuna C, Reiter RJ, Acu ña-Castroviejo D, Guerrero JM. Melatonin reduces nitric oxide synthase activity in rat hypothalamus. J Pineal Res 1996;20:205-10.
19. Szárszoi O, Asemu G, Vanecek J, Ost'ádal B, Kolár F. Effects of melatonin on ischemia and reperfusion injury of the rat heart. Cardiovasc Drugs Ther 2001;15:251-7.
20. Bolli R. Oxygen-derived free radicals and myocardial reperfusion injury: an overview. Cardiovasc Drugs Ther 1991;5 Suppl 2:249-68.
21. Pieri C, Marra M, Moroni F, Recchioni R, Marcheselli F. Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 1994;55:PL271-6.
22. Sewerynek E, Reiter RJ, Melchiorri D, Ortiz GG, Lewinski A. Oxidative damage in the liver induced by ischemia-reperfusion: protection by melatonin. Hepato-Gastroenterology 1996;43:898-905.
23. Inci I, Inci D, Dutly A, Boehler A, Weder W. Melatonin attenuates posttransplant lung ischemia-reperfusion injury. Ann Thorac Surg 2000;73:220-5.
24. Kazez A, Demirbaǧ M, Ustündaǧ B, Ozercan IH, Saǧlam M. The role of melatonin in prevention of intestinal ischemia-reperfusion injury in rats. J Pediatr Surg 2000;35:1444-8.
25. Wakatsuki A, Okatani Y, Izumiya C, Ikenoue N. Melatonin protects against ischemia and reperfusion-induced oxidative lipid and DNA damage in fetal rat brain. J Pineal Res 1999;26:147-52.